Search
Research
Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in AustraliaAustralia's active vaccine safety surveillance system AusVaxSafety monitors a number of vaccines, including Arexvy, by reporting on solicited adverse events following immunisation (AEFI) through an online survey sent to vaccinees 3 days post-vaccination as previously described.3 Here we report on survey responses from adults aged ≥60 years receiving Arexvy at primary healthcare practices or pharmacies, who responded to the survey by day 7 post-vaccination.

Research
Multigenerational Familial and Environmental Risk for Autism (MINERvA) NetworkThe MINERvA Network will allow more accurate and precise determination of the contributions of familial and environmental factors to the etiology of autism.

BioSpecs is a flexible service that supports laboratory research by providing expert technical assistance in pre-analytical sample processing and nucleic acid extractions.
Research
WA Aboriginal Health Knowledge NetworkA Network comprised of four regional sites to facilitate key medical, research and training activities undertaken in partnership with Aboriginal communities.

The Third Conversation

Professor Jonathan Carapetis has made eliminating rheumatic heart disease his life’s work.

Children in the tiny Pacific nation of Tuvalu face a unique threat that should be a wake-up call to other countries across the world.

In 2020, the National Closing the Gap partnership made improving early development of Aboriginal and Torres Strait Islander children one of its top priorities. Australia will measure progress in this area using the AEDC.

The Kids Research Institute Australia Government Relations Advisor Fiona Roche said the BEACHES project was a great example of how the Institute is increasingly working in partnership with Government

Lucia Wright is a happy, confident 16-year-old who loves her family, friends, drama, science and making the most of her newfound independence.